Liu Jian-Jun, Yeoh Lee Ying, Sum Chee Fang, Tavintharan Subramaniam, Ng Xiao Wei, Liu Sylvia, Lee Simon B M, Tang Wern Ee, Lim Su Chi
Clinical Research Unit, Khoo Teck Puat Hospital, 768828 Singapore.
Diabetes Centre, Khoo Teck Puat Hospital, 768828 Singapore.
J Diabetes Complications. 2015 Jul;29(5):707-12. doi: 10.1016/j.jdiacomp.2015.02.011. Epub 2015 Feb 28.
The association of adhesion molecules ICAM-1 and VCAM-1 with cardiovascular diseases has been well-studied. However, their roles in diabetic kidney disease (DKD) are incompletely understood. We aim to study the association of plasma ICAM-1 and VCAM-1 with DKD in Asians with type 2 diabetes (T2DM).
A total of 1950 Asians with T2DM were included in this cross-sectional study. Plasma ICAM-1 and VCAM-1 were measured by immunoassays.
Renal filtration function (eGFR) declined and urinary albumin-to-creatinine ratio (ACR) levels increased progressively with the increase in plasma VCAM-1 levels. In contrast, no significant changes in eGFR and ACR were observed in subjects across different plasma ICAM-1 levels. Both ICAM-1 and VCAM-1 were correlated with ACR (rho = 0.153, p < 0.001 for VCAM-1 and ACR; rho = 0.053, p = 0.020 for ICAM-1 and ACR) in bivariate correlation analysis. However, only VCAM-1 was correlated with eGFR (rho = -0.228, p < 0.001). Multivariable linear regression models revealed that VCAM-1, but not ICAM-1, was independently associated with eGFR and albuminuria. Backward linear regression suggested that plasma VCAM-1 variability was mainly determined by eGFR whereas plasma ICAM-1 level was mainly determined by C-reactive protein in patients with T2DM.
Plasma VCAM-1 level, but not ICAM-1 level, was independently associated with prevalent DKD in Asians with T2DM. High level of ICAM-1 may be indicative of systemic inflammation and portends increase risk of incipient DKD.
黏附分子细胞间黏附分子-1(ICAM-1)和血管细胞黏附分子-1(VCAM-1)与心血管疾病的关联已得到充分研究。然而,它们在糖尿病肾病(DKD)中的作用尚未完全明确。我们旨在研究血浆ICAM-1和VCAM-1与亚洲2型糖尿病(T2DM)患者DKD的关联。
本横断面研究共纳入1950例亚洲T2DM患者。采用免疫分析法检测血浆ICAM-1和VCAM-1。
随着血浆VCAM-1水平升高,肾脏滤过功能(估算肾小球滤过率,eGFR)下降,尿白蛋白与肌酐比值(ACR)水平逐渐升高。相比之下,不同血浆ICAM-1水平的受试者eGFR和ACR未观察到显著变化。双变量相关性分析显示,ICAM-1和VCAM-1均与ACR相关(VCAM-1与ACR的相关系数rho = 0.153,p < 0.001;ICAM-1与ACR的相关系数rho = 0.053,p = 0.020)。然而,只有VCAM-1与eGFR相关(rho = -0.228,p < 0.001)。多变量线性回归模型显示,VCAM-1而非ICAM-1与eGFR和蛋白尿独立相关。向后线性回归表明,T2DM患者血浆VCAM-1变异性主要由eGFR决定,而血浆ICAM-1水平主要由C反应蛋白决定。
在亚洲T2DM患者中,血浆VCAM-1水平而非ICAM-1水平与DKD患病率独立相关。高水平的ICAM-1可能提示全身炎症,并预示早期DKD风险增加。